BSEInsider Trading / SAST2d ago · 23 Sept 2026, 01:11 pm
Closure of Trading Window for quarter ended September 30,2026
Aspira Pathlab & Diagnostics Ltd · 540788
✦ AI Summary
Aspira Pathlab & Diagnostics Ltd has announced the closure of its trading window for dealing in securities from October 1, 2026, until the declaration of financial results for the half year ended September 30, 2026, and 48 hours thereafter. The company has informed the BSE that this is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
dc2ccce2-eab9-46a1-8220-9e2cdc850749.pdf
View document text
Aspira Pathlab & Diagnostics Limited
Registered. Office: Flat No. 2, R D Shah Building, Shraddhanand
Road, Opp. Railway Station, Ghatkopar (W), Mumbai-400086
Corporate Office: 6 & 7, Bhaveshwar Arcade, Near Shreyas Junction
LBS Marg, Behind Saraswat Bank, Ghatkopar (W), Mumbai-400086
CIN: L85100MH1973PLC289209
Date: September 23, 2026
Listing Department,
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai-400001.
Scrip Code: 540788
Security ID: ASPIRA
Sub: Closure of Trading Window
Ref: SEBI (Prohibition of Insider Trading) Regulations, 2015
This is to inform that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 (as
amended) and the Company’s Code of Conduct for Prevention of Insider Trading, the Trading Window
for dealing in the securities of the Company shall remain closed for Designated Persons and their
immediate relatives w.e.f October 01, 2026 till the declaration of Financial Results for the half year
ended September 30, 2026 and 48 (Forty-eight) hours thereafter.
The date of the Board Meeting for declaration of the Financial Results for the half year ended
September 30, 2026 shall be intimated in the due course.
You are requested to kindly take the above on you records.
Thanking you.
Yours sincerely.
For Aspira Pathlab & Diagnostics Limited
Neetu Maurya
Company Secretary & Compliance Officer
INDIA’S FIRST 0227197 5756, 022 2513 9090 www.aspiradiagnostics.com
FULLY INTEGRATED LAB support@aspiradiagnostics.com │info@aspiradiagnostics.com